Tampa General Hospital Cancer Institute — Tampa, Florida

Tampa General Hospital Cancer Institute is a clinical research site located in Tampa, Florida, United States 33606.

Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.

Tampa General Hospital Cancer Institute has participated in 5 clinical trials with 3 currently active.

Therapeutic areas: Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer.

Sponsors: Regeneron Pharmaceuticals, Pfizer, BeOne Medicines.

Sponsor Feasibility Report

Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tampa General Hospital Cancer Institute?

Tampa General Hospital Cancer Institute has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tampa General Hospital Cancer Institute conducted?

Tampa General Hospital Cancer Institute has 5 clinical trials on record, with 3 currently active. Their work covers Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer.

Is Tampa General Hospital Cancer Institute accredited by Crixeo Health?

Tampa General Hospital Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Tampa General Hospital Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.